Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

In a record-breaking span of just 11 months, Moderna created, developed, manufactured, and got regulatory authorization for mRNA-1273, a two-dose covid vaccine that is one of the first two mRNA ...

Don't Miss: Today’s deals: $17.50 Apple AirTags, $50 off Madden NFL 25, $30 Crock-Pot Electric Lunch Box, more Produced by Moderna, the proposed vaccine (mRNA-1273) has been in trial for more ...

DRS of mRNA-1273 reveals the CCR4–NOT-mediated dynamics of its poly(A) tail in model cell lines. Credit: Nature (2025). DOI: 10.1038/s41586-025-08842-1 ...

4/5 and ancestral SARS-CoV-2 than mRNA-1273, with the highest geometric mean titer ratios observed in adults and in the subset of participants aged 65 years and older,” Moderna said. The new ...

and colleagues compared the prevalence of major structural birth defects by COVID-19 vaccination status and compared the prevalence by brand (Moderna mRNA-1273 versus Pfizer-BioNTech BNT162b2 ...

technology booster vaccines (mRNA-1273.214 and mRNA-1273.222) have a superior antibody response compared to a booster dose of the basic RNA vaccine. “We are pleased to see that our two bivalent ...

and mRNA-1273 (Moderna) vaccine, respectively. This contrasts with 10 extra cases of myocarditis per 1 million positive SARS-CoV-2 tests (figure 1).1 However, no confirmed cases of athletes with ...